PFIZER BEGINS VACCINE TRIAL IN PREGNANT WOMEN IN A BID TO FILL GLOBAL DATA VOID

  • 18/02/2021

Pfizer Inc. and BioNTech SE are starting trials for their vaccine in 4,000 women in the latter stages of pregnancy. They will run a mid-stage study for 350 volunteers between 27 and 34 weeks gestation to confirm safety before moving into advanced trials for women between 24 and 34 weeks pregnant. 

AstraZeneca Plc. and Johnson & Johnson are planning to run trials in the coming months. It’s good news for pregnant people, who until now have faced a difficult dilemma: excluded from vaccine studies, yet more vulnerable to severe Covid-19. Some studies have also linked the disease to premature birth.

Related News

Israel PM reaffirms his plan to attack Rafah with ground for ...
  • 12/03/2024
Pakistan ex-PM Imran Khan jailed for 10 years
  • 30/01/2024
ICJ orders Israel to stop genocide acts in Gaza
  • 26/01/2024
Iran bomb blast: More than 100 killed
  • 03/01/2024
Russia-Ukraine war: 14 killed in Russia’s Belgorod in shelli ...
  • 30/12/2023
Russia-Ukraine war: Biggest aerial attack on Ukraine cities
  • 30/12/2023
South Africa launches genocide case against Israel at UN Cou ...
  • 30/12/2023
Pakistan PM declares prohibition on New Year festivities
  • 30/12/2023
Health Ministry of Gaza: 20,057 people dead
  • 22/12/2023
Gaza Health Ministry: Over 15,500 killed in Gaza
  • 09/12/2023
14 dead in a fire at university dormitory in Iraq
  • 08/12/2023
Mount Merapi eruption: 11 hikers dead
  • 04/12/2023